Bulletin
Investor Alert

Market Snapshot Archives | Email alerts

Sept. 14, 2020, 4:43 p.m. EDT

Dow ends 327 points higher as stocks rebound amid vaccine hopes, IPO rush and corporate deal-making

Snowflake to kick off year’s biggest week so far for IPOs

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Dow Jones Industrial Average (DJIA)
  • X
    S&P 500 Index (SPX)
  • X
    NASDAQ Composite Index (COMP)

or Cancel Already have a watchlist? Log In

By Joy Wiltermuth and Sunny Oh


AFP/Getty Images

U.S. stocks rose Monday, taking back a chunk of last week’s losses amid fresh hope for a coronavirus vaccine, a flurry of initial public offerings and potential corporate mash-ups, including reports that Oracle plans to forge a partnership with TikTok, the popular China-based social-media platform.

How did equity benchmarks perform?

The Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.10% rose 327.69 points, or 1.2%, to finish at 27,993.33, after briefly trading above the 28,000 threshold. The S&P 500 /zigman2/quotes/210599714/realtime SPX +0.34% added 42.57 points, or 1.3%, closing at 3,383.54. The Nasdaq Composite /zigman2/quotes/210598365/realtime COMP +0.37% climbed 203.11 points, or 1.7%, to end at 11,056.65, snapping a two-session losing streak.

The Russell 2000 index /zigman2/quotes/210598147/delayed RUT +0.63% of small-capitalization stocks rose 39.70 points, or 2.7%, to end at 1,536.97, outperforming the major stock benchmarks.

Equities ended Friday with the Dow posting a weekly loss of 1.7%, while the S&P 500 fell 2.5% and the Nasdaq Composite Index dropped 4.1%, marking its worst weekly plunge since the period ended March 20, according to Dow Jones Market Data.

What drove the market?

Equities on Wall Street closed higher on Monday, as investors embraced positive developments on the vaccine front and geared up for the year’s busiest week so far for initial public offerings.

Snowflake, a cloud-computing company, looks to lead the way, with plans to raise up to $3.08 billion at a valuation of up to $30.5 billion. A dozen companies are on tap to go public for the week, while aiming to raise a collective $6.8 billion.

Read : IPO market gears up for busiest week since May of 2019 — Uber’s IPO week — with 12 deals on tap

“That’s another positive affecting the market today,” said John Carey, director of U.S. equity income at Amundi Pioneer, of the slate of IPO and large batch of corporate tie-ups announced over the weekend.

“Otherwise, we’ve got terrible fires in the Western part of the country that’s just devastating, civil unrest and an acrimonious political environment as this campaign season heats up,” he told MarketWatch. “Certainly, other things could be front-and-center any other week,” he said, adding that instead it’s “off to the races.”

President Donald Trump visited the Sacramento, Calif., area on Monday and argued with Wade Crowfoot, California’s secretary for natural resources, about climate change’s role in the wildfires raging in the West. Joe Biden, campaigning in Delaware in his bid for the White House, attacked Trump’s responses to the wildfires and climate change on Monday, saying the fires represent “yet another crisis he won’t take responsibility for.”

Major stock indexes were led higher Monday by shares of financial, energy and real-estate companies, after last week’s market turbulence led the technology-heavy Nasdaq Composite to post its steepest weekly decline since the height of the pandemic-driven selloff in March.

Renewed hopes of a COVID-19 vaccine also were credited with sparking the move higher on Wall Street.

Notably, AstraZeneca PLC /zigman2/quotes/200304487/composite AZN +0.08%  said over the weekend that U.K. clinical trials for its experimental coronavirus vaccine resumed after trials were paused due to an unexplained illness contracted by one of the participants who was given the vaccine. However, a restart of the trials in the U.S. remains on hold until at least midweek, until the U.S. Food and Drug Administration and a safety panel investigate the case, Reuters reported.

Pfizer Inc .’s /zigman2/quotes/202877789/composite PFE +2.00% CEO Albert Bourla in an interview with CBS News’ “Face the Nation,” on Sunday said the pharmaceutical giant should know if its own experimental COVID-19 vaccine works by the end of October — and if approved, it could be distributed in the U.S. by the end of the year.

/zigman2/quotes/210598065/realtime
US : Dow Jones Global
28,335.57
-28.09 -0.10%
Volume: 350.10M
Oct. 23, 2020 5:15p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,465.39
+11.90 +0.34%
Volume: 2.16B
Oct. 23, 2020 5:15p
loading...
/zigman2/quotes/210598365/realtime
US : U.S.: Nasdaq
11,548.28
+42.28 +0.37%
Volume: 2.88M
Oct. 23, 2020 5:16p
loading...
/zigman2/quotes/210598147/delayed
US : US Composite
1,640.50
+10.25 +0.63%
Volume: 1.24M
Oct. 23, 2020 4:30p
loading...
/zigman2/quotes/200304487/composite
US : U.S.: Nasdaq
$ 52.00
+0.04 +0.08%
Volume: 5.58M
Oct. 23, 2020 4:00p
P/E Ratio
63.41
Dividend Yield
2.63%
Market Cap
$135.95 billion
Rev. per Employee
$342,432
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 38.18
+0.75 +2.00%
Volume: 28.99M
Oct. 23, 2020 4:02p
P/E Ratio
15.18
Dividend Yield
3.98%
Market Cap
$212.16 billion
Rev. per Employee
$580,595
loading...
1 2
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

World News from MarketWatch

Link to MarketWatch's Slice.